KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsCash from RestructuringChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShare-based CompensationShare-based CompensationShares IssuedShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Other financing activities (2016 - 2024)

West Pharmaceutical Services has reported Other financing activities over the past 14 years, most recently at -$100000.0 for Q1 2024.

  • Quarterly Other financing activities changed N/A to -$100000.0 in Q1 2024 from the year-ago period, while the trailing twelve-month figure was -$100000.0 through Mar 2024, down 200.0% year-over-year, with the annual reading at $1.2 million for FY2022, N/A changed from the prior year.
  • Other financing activities was -$100000.0 for Q1 2024 at West Pharmaceutical Services, roughly flat from -$100000.0 in the prior quarter.
  • Over five years, Other financing activities peaked at $2.3 million in Q4 2020 and troughed at -$100000.0 in Q4 2022.
  • The 3-year median for Other financing activities is $200000.0 (2022), against an average of $680000.0.
  • Peak annual rise in Other financing activities hit 387.5% in 2020, while the deepest fall reached 387.5% in 2020.
  • Tracing WST's Other financing activities over 3 years: stood at $2.3 million in 2020, then crashed by 104.35% to -$100000.0 in 2022, then changed by 0.0% to -$100000.0 in 2024.
  • According to Business Quant data, Other financing activities over the past three periods came in at -$100000.0, -$100000.0, and $200000.0 for Q1 2024, Q4 2022, and Q2 2022 respectively.